16 research outputs found

    Ag–ZnO Nanocomposites as a 3D Metal-Enhanced Fluorescence Substrate for the Fluorescence Detection of DNA

    No full text
    Fluorescence enhancement, including metal-enhanced fluorescence (MEF), has been widely explored in the field of biosensor technology. Two- and three-dimensional (2D and 3D) MEF substrate approaches have been developed for biosensors to detect target biomarkers such as genes and proteins. However, several issues remain, not least poor reproducibility caused by limited recognition and diffusion of biomolecules among target molecules, biological probes, and MEF substrates in aqueous environments. Here, an Ag–ZnO nanocomplex as a 3D MEF substrate was developed in two steps: hydrothermal synthesis of ZnO nanowire (NW) as a building block of Ag nanoparticles (NPs), and photochemical deposition of AgNPs on the ZnO NW. Fluorescence enhancement on Ag–ZnO nanocomposites (NCs) compared with the glass substrate was 14.8-, 16.9-, 11.4-, and 14.2-fold in the presence of 10, 20, 40, and 60 base pair (bp) double-stranded (ds) DNA, respectively. The MEF effects on glass, ZnO NW, and Ag–ZnO NCs were analyzed by measuring the fluorescence lifetime of fluorescein (FAM)-labeled dsDNA, and the average lifetimes were 9.76, 9.34, and 7.86 ns, respectively. Ag–ZnO NCs showed a 50-fold higher sensitivity for the detection of dsDNA than Ag nanoisland film (AgNIF) as a 2D MEF substrate. Therefore, Ag–ZnO NCs may have potential as a 3D MEF substrate. The MEF phenomenon might involve broad-range interactions between the surface of the metal nanostructure on Ag–ZnO NCs and fluorophores in various scenarios. Our Ag–ZnO NCs could facilitate the development of sensitive MEF-based biosensors for DNA detection

    Enhanced Electrochemical and Photocatalytic Performance of Core–Shell CuS@Carbon Quantum Dots@Carbon Hollow Nanospheres

    No full text
    A controlled structural morphology, high specific surface area, large void space, and excellent biocompatibility are typical favorable properties in electrochemical energy storage and photocatalytic studies; however, a complete understanding about this essential topic still remains a great challenge. Herein, we have developed a new type of functionalized carbon hollow-structured nanospheres based on core–shell copper sulfide@carbon quantum dots (CQDs)@carbon hollow nanosphere (CHNS) architecture. This CuS@CQDs@C HNS is accomplished by a simple, scalable, <i>in situ</i> single-step hydrothermal method to produce the material that can be employed as an electrode for electrochemical energy storage and photocatalytic applications. Impressively, the CuS@CQDs@C HNS nanostructure delivers exceptional electrochemical energy storage characteristics with high specific capacitance (618 F g<sup>–1</sup> at a current density of 1 A g<sup>–1</sup>) and an excellent rate capability with an extraordinary capacitance (462 F g<sup>–1</sup> at current density of 20 A g<sup>–1</sup>) and long cycle life (95% capacitance retention after 4000 cycles). Further, the proposed photocatalyst exhibited superior photocatalytic activity under solar light due to the efficient electron transfer, which was revealed by photoluminescence studies. Such superior electrochemical and photocatalytic performance can be ascribed to the mutual contribution of CuS, CQDs, and CHNS and unique core–shell architecture. These results exhibit that the core–shell CuS@CQDs@C HNS nanostructure is one of the potential candidates for supercapacitors and photocatalytic applications

    Hierarchical Heterostructures of Ultrasmall Fe<sub>2</sub>O<sub>3</sub>‑Encapsulated MoS<sub>2</sub>/N-Graphene as an Effective Catalyst for Oxygen Reduction Reaction

    No full text
    In this study, a facile approach has been successfully applied to synthesize a hierarchical three-dimensional architecture of ultrasmall hematite nanoparticles homogeneously encapsulated in MoS<sub>2</sub>/nitrogen-doped graphene nanosheets, as a novel non-Pt cathodic catalyst for oxygen reduction reaction in fuel cell applications. The intrinsic topological characteristics along with unique physicochemical properties allowed this catalyst to facilitate oxygen adsorption and sped up the reduction kinetics through fast heterogeneous decomposition of oxygen to final products. As a result, the catalyst exhibited outstanding catalytic performance with a high electron-transfer number of 3.91–3.96, which was comparable to that of the Pt/C product. Furthermore, its working stability with a retention of 96.1% after 30 000 s and excellent alcohol tolerance were found to be significantly better than those for the Pt/C product. This hybrid can be considered as a highly potential non-Pt catalyst for practical oxygen reduction reaction application in requirement of low cost, facile production, high catalytic behavior, and excellent stability

    Highly Active and Durable Core–Shell fct-PdFe@Pd Nanoparticles Encapsulated NG as an Efficient Catalyst for Oxygen Reduction Reaction

    No full text
    Development of highly active and durable catalysts for oxygen reduction reaction (ORR) alternative to Pt-based catalyst is an essential topic of interest in the research community but a challenging task. Here, we have developed a new type of face-centered tetragonal (fct) PdFe-alloy nanoparticle-encapsulated Pd (fct-PdFe@Pd) anchored onto nitrogen-doped graphene (NG). This core–shell fct-PdFe@Pd@NG hybrid is fabricated by a facile and cost-effective technique. The effect of temperature on the transformation of face-centered cubic (fcc) to fct structure and their effect on ORR activity are systematically investigated. The core–shell fct-PdFe@Pd@NG hybrid exerts high synergistic interaction between fct-PdFe@Pd NPs and NG shell, beneficial to enhance the catalytic ORR activity and excellent durability. Impressively, core–shell fct-PdFe@Pd@NG hybrid exhibits an excellent catalytic activity for ORR with an onset potential of ∼0.97 V and a half-wave potential of ∼0.83 V versus relative hydrogen electrode, ultrahigh current density, and decent durability after 10 000 potential cycles, which is significantly higher than that of marketable Pt/C catalyst. Furthermore, the core–shell fct-PdFe@Pd@NG hybrid also shows excellent tolerance to methanol, unlike the commercial Pt/C catalyst. Thus, these findings open a new protocol for fabricating another core–shell hybrid by facile and cost-effective techniques, emphasizing great prospect in next-generation energy conversion and storage applications

    Facile Method for the Preparation of Water Dispersible Graphene using Sulfonated Poly(ether–ether–ketone) and Its Application as Energy Storage Materials

    No full text
    A simple and effective method for the preparation of water dispersible graphene using sulfonated poly­(ether–ether–ketone) (SPEEK) has been described. The SPEEK macromolecules are noncovalently adsorbed on the surface of graphene through π–π interactions. The SPEEK-modified graphene (SPG) forms an aqueous dispersion that is stable for more than six months. An analysis of the ultraviolet–visible spectra shows that the aqueous dispersion of SPG obeys Beer’s law and the molar extinction coefficient has been found to be 149.03 mL mg<sup>–1</sup> cm<sup>–1</sup>. Fourier transform infrared, Raman, and X-ray photoelectron spectroscopy analyses confirm successful reduction and surface modification of graphene. An atomic force microscopy (AFM) analysis reveals the formation of a single layer of functionalized graphene. Transmission electron microscopy results are also in good agreement with the AFM analysis and support the formation of single-layer graphene. SPG shows good electrochemical cyclic stability during cyclic voltammetry and charge/discharge process when used as a supercapacitor electrode. A specific capacitance of 476 F g<sup>–1</sup> at a current density of 6.6 A g<sup>–1</sup> is observed for SPG materials

    Table1_Metformin acts as a dual glucose regulator in mouse brain.DOCX

    No full text
    Aims: Metformin improves glucose regulation through various mechanisms in the periphery. Our previous study revealed that oral intake of metformin activates several brain regions, including the hypothalamus, and directly activates hypothalamic S6 kinase in mice. In this study, we aimed to identify the direct effects of metformin on glucose regulation in the brain.Materials and methods: We investigated the role of metformin in peripheral glucose regulation by directly administering metformin intracerebroventricularly in mice. The effect of centrally administered metformin (central metformin) on peripheral glucose regulation was evaluated by oral or intraperitoneal glucose, insulin, and pyruvate tolerance tests. Hepatic gluconeogenesis and gastric emptying were assessed to elucidate the underlying mechanisms. Liver-specific and systemic sympathetic denervation were performed.Results: Central metformin improved the glycemic response to oral glucose load in mice compared to that in the control group, and worsened the response to intraperitoneal glucose load, indicating its dual role in peripheral glucose regulation. It lowered the ability of insulin to decrease serum glucose levels and worsened the glycemic response to pyruvate load relative to the control group. Furthermore, it increased the expression of hepatic G6pc and decreased the phosphorylation of STAT3, suggesting that central metformin increased hepatic glucose production. The effect was mediated by sympathetic nervous system activation. In contrast, it induced a significant delay in gastric emptying in mice, suggesting its potent role in suppressing intestinal glucose absorption.Conclusion: Central metformin improves glucose tolerance by delaying gastric emptying through the brain-gut axis, but at the same time worsens it by increasing hepatic glucose production via the brain-liver axis. However, with its ordinary intake, central metformin may effectively enhance its glucose-lowering effect through the brain-gut axis, which could surpass its effect on glucose regulation via the brain-liver axis.</p

    CdS-CoFe<sub>2</sub>O<sub>4</sub>@Reduced Graphene Oxide Nanohybrid: An Excellent Electrode Material for Supercapacitor Applications

    No full text
    CoFe<sub>2</sub>O<sub>4</sub> nanospheres ornamented CdS nanorods were successfully assembled over the reduced graphene oxide nanosheets. Such hierarchical morphology established by field emission scanning electron microscopy and transmission electron microscopy studies, with high surface area offered a high specific capacitance of 1487 F g<sup>–1</sup> at a current density of 5 A g<sup>–1</sup> owing to fast diffusion of ions, facile transportation of electrons, and great synergism between the components, which led to reversible redox reactions. Furthermore, the electrode material has specific capacitance retention of 78% up to 5000 cycles, thus demonstrating its good reversibility and cyclic stability. The resulting CdS-CoFe<sub>2</sub>O<sub>4</sub>@reduced graphene oxide nanohybrid can deliver excellent electrochemical performance and can be a potential candidate for supercapacitor application

    Body Mass Index and Mortality in the General Population and in Subjects with Chronic Disease in Korea: A Nationwide Cohort Study (2002-2010)

    No full text
    <div><p>Background</p><p>The association between body mass index (BMI) and mortality is not conclusive, especially in East Asian populations. Furthermore, the association has been neither supported by recent data, nor assessed after controlling for weight changes.</p><p>Methods</p><p>We evaluated the relationship between BMI and all-cause or cause-specific mortality, using prospective cohort data by the National Health Insurance Service in Korea, which consisted of more than one million subjects. A total of 153,484 Korean adults over 30 years of age without pre-existing cardiovascular disease or cancer at baseline were followed-up until 2010 (mean follow-up period = 7.91 ± 0.59 years). Study subjects repeatedly measured body weight 3.99 times, on average.</p><p>Results</p><p>During follow-up, 3,937 total deaths occurred; 557 deaths from cardiovascular disease, and 1,224 from cancer. In multiple-adjusted analyses, U-shaped associations were found between BMI and mortality from any cause, cardiovascular disease, and cancer after adjustment for age, sex, smoking status, alcohol consumption, physical activity, socioeconomic status, and weight change. Subjects with a BMI < 23 kg/m<sup>2</sup> and ≥ 30 kg/m<sup>2</sup> had higher risks of all-cause and cause-specific mortality compared with the reference group (BMI 23–24.9 kg/m<sup>2</sup>). The lowest risk of all-cause mortality was observed in subjects with a BMI of 25–26.4 kg/m<sup>2</sup> (adjusted hazard ratio [HR] 0.86; 95% CI 0.77 to 0.97). In subgroup analyses, including the elderly and those with chronic diseases (diabetes mellitus, hypertension, and chronic kidney disease), subjects with a BMI of 25–29.9 kg/m<sup>2</sup> (moderate obesity) had a lower risk of mortality compared with the reference. However, this association has been attenuated in younger individuals, in those with higher socioeconomic status, and those without chronic diseases.</p><p>Conclusion</p><p>Moderate obesity was associated more strongly with a lower risk of mortality than with normal, underweight, and overweight groups in the general population of South Korea. This obesity paradox was prominent in not only the elderly but also individuals with chronic disease.</p></div

    U-shaped association between sleep duration and urinary albumin excretion in Korean adults: 2011-2014 Korea National Health and Nutrition Examination Survey

    No full text
    <div><p>Although sleep duration has been extensively studied in metabolic diseases, few studies have investigated the impact of sleep duration on chronic kidney disease. The aim of this study was to examine the relationship between sleep duration and albuminuria in the general population. Among 24,948 adults who participated in the 2011–2014 KNHANES, a total of 19,994 subjects were included in this analysis. Subjects were categorized into the following five groups according to self-reported sleep duration: less than 5 h, 6 h, 7 h, 8 h, and more than 9 h. The association between sleep duration and urinary albumin-creatinine ratio (UACR) was examined cross-sectionally. Subjects with both short and long sleep durations were significantly associated with higher UACR levels and higher proportions of patients with microalbuminuria (30–299 mg/g) and macroalbuminuria (≥300 mg/g) compared to those with a sleep duration of 7 hours. The U-shaped association between sleep duration and UACR remained significant even after adjustment for potential confounders, including age, sex, body mass index, smoking, alcohol, education, income, exercise, estimated glomerular filtration rate, diabetes mellitus, hypertension and hypercholesterolemia. The U-shaped association is more evident in the subgroup aged 65 or older, or in female subjects. Our findings suggest that both short and long sleep durations have a U-shaped association with UACR levels in the general population, independent of potential confounders.</p></div
    corecore